Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Biomea Fusion, Inc. BMEA surged 56.8% to $24.20 after the company announced data from the initial cohorts of the ongoing Phase II study of BMF-219 in patients with type 2 diabetes; 100mg cohort 3 demonstrated an 89% response rate and 1% median reduction in HbA1c at day 28.
• Oscar Health, Inc. OSCR shares jumped 54.9% to $5.54 after the company announced the appointment of healthcare veteran Mark Bertolini as CEO effective April 3, 2023.
• Biodexa Pharmaceuticals BDRX shares jumped 52% to $0.7150 after gaining 65% on Monday.
• Viking Therapeutics, Inc. VKTX gained 46.8% to $13.39 after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of various metabolic disorders.
• Beamr Imaging Ltd. BMR rose 33.3% to $2.9745.
• Mercurity Fintech Holding Inc. MFH surged 26% to $1.7698.
• Bird Global, Inc. BRDS gained 24.4% to $0.17. Bird, on Monday, announced purchases of shares by management and directors.
• ZW Data Action Technologies Inc. CNET gained 23.5% to $2.15. ZW Data Action Technologies entered into cooperation agreement with Chaineffect (Guangzhou) Blockchain Technology.
• Intra-Cellular Therapies, Inc. ITCI shares surged 20% to $57.48 after the company announced topline results from Study 403 evaluating lumateperone as monotherapy in patients with major depressive disorder with mixed features and bipolar depression with mixed features.
• PVH Corp. PVH rose 19% to $87.57 after the company posted better-than-expected results for its fourth quarter and issued strong FY23 earnings forecast.
• Guardion Health Sciences, Inc. GHSI climbed 18.3% to $7.38.
• Milestone Pharmaceuticals Inc. MIST gained 15.3% to $4.1506. Milestone Pharmaceuticals announced a $125 million strategic funding with an existing shareholder.
• The Lovesac Company LOVE rose 14.7% to $27.52 after the company announced better-than-expected Q4 EPS and sales results and issued FY24 EPS and sales guidance above estimates.
• Silvergate Capital Corporation SI shares rose 13.7% to $2.24. Silvergate Capital shares gained around 15% on Monday after MacroStrategy reported it voluntarily prepaid its Silvergate Bank loan. MicroStrategy prepaid approximately $161.0 million.
• McCormick & Company, Incorporated MKC gained 12.2% to $83.14. McCormick & Co reported first-quarter FY23 sales growth of 3% year-on-year to $1.57 billion, beating the consensus of $1.54 billion.
• Purple Innovation, Inc. PRPL surged 11.8% to $2.8085.
• IHS Holding Limited IHS jumped 11.6% to $7.92 following Q4 results.
• Standard Lithium Ltd. SLI gained 10.9% to $3.6385.
• Cidara Therapeutics, Inc. CDTX shares rose 9.9% to $1.11. Cidara Therapeutics President and CEO Jeffrey Stein acquired a total 50,000 shares at an average price of $1.04.
• Alibaba Group Holding Limited BABA gained 8.3% to $93.31 following a report suggesting the company will be splitting into six units that may pursue individual IPOs.
• Proterra Inc. PTRA gained 8.3% to $1.57.

Losers

• Monopar Therapeutics Inc. MNPR shares declined 49.8% to $1.4890 after the company announced it will be discontinuing its Validive Phase 2b/3 VOICE trial along with the active development of Validive after the company was informed the trial didn't meet the pre-defined threshold for efficacy.
• Virgin Orbit Holdings, Inc. VORB shares dropped 27% to $ 0.39. Virgin Orbit is extending its pause in operation to pursue investment, CNBC reported, citing a company-wide mail by CEO Dan Hart.
• Harmony Biosciences Holdings, Inc. HRMY fell 26.4% to $30.53 after Scorpion Capital issued a short report on the company.
• WiSA Technologies, Inc. WISA fell 25.7% to $2.67 after jumping around 89% on Monday.
• OncoSec Medical Incorporated ONCS shares fell 20.5% to $2.10.
• TRxADE HEALTH, Inc. MEDS dropped 20.3% to $0.3625 following a wider-than-expected quarterly loss.
• Draganfly Inc. DPRO fell 18.2% to $1.43 after posting a loss for the fourth quarter.
• Better Choice Company Inc. BTTR dropped 16.6% to $0.3701 following weak quarterly sales.
• Boxed, Inc. BOXD declined 14.3% to $0.1740.
• Allarity Therapeutics, Inc. ALLR dropped 12.8% to $2.2399. Allarity Therapeutics said that for Ixempra and stenoparib monotherapy trials, Allarity is taking steps to accelerate patient recruitment to support the goals for interim data readouts by the end of 2023.
• Finch Therapeutics Group, Inc. FNCH fell 12.5% to $0.35. Finch Therapeutics Group recently posted a Q4 loss of $0.56 per share.
• iHeartMedia, Inc. IHRT dipped 11.6% to $3.79. B of A Securities downgraded iHeartMedia from Neutral to Underperform and lowered the price target from $6.5 to $4.
• Puyi Inc. PUYI fell 11.2% to $5.77.
• CytomX Therapeutics, Inc. CTMX fell 10.1% to $1.61 after the company posted results for its fourth quarter.
• BM Technologies, Inc. BMTX dropped 9.6% to $3.48 following weak quarterly sales.
• Invesco Mortgage Capital Inc. IVR fell 5% to $10.64 after the company announced a cash dividend of $0.40 per share of common stock for the first quarter and issued an update on estimated results of operations, portfolio, liquidity and book value.

Now Read This: Bitcoin Falls Below $27,000; Mina, Arbitrum Among Top Losers